The Veterinary Record Link to Vetlife website
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Platt, S. R.
Right arrow Articles by Matiasek, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Platt, S. R.
Right arrow Articles by Matiasek, L.
The Veterinary Record 159:881-884 (2006)
© 2006 British Veterinary Association

Papers and Articles

Treatment with gabapentin of 11 dogs with refractory idiopathic epilepsy

S. R. Platt, BVM&S, DipACVIM, DipECVN, MRCVS1, V. Adams, BSc, DVM, MSc, PhD2, L. S. Garosi, DVM, DipECVN, MRCVS1, C. J. Abramson, DVM, DipACVIM3, J. Penderis, BVSc, MVM, PhD, CertVR, DipECVN, MRCVS1, A. De Stefani, DVM, MRCVS1 and L. Matiasek, DVM, MRCVS1

1 Centre for Small Animal Studies, Animal Health Trust, Lanwades Park, Newmarket, Suffolk CB8 7UU
2 Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Newmarket, Suffolk CB8 7UU
3 Department of Veterinary Clinical Sciences, Ohio State University, 601 Vernon L. Tharp Street, Columbus, OH 43210, USA

Eleven dogs diagnosed with refractory idiopathic epilepsy were treated orally with gabapentin for a minimum of three months at an initial dose of 10 mg/kg every eight hours. They were all experiencing episodes of generalised tonic-clonic seizures and had been treated chronically with a combination of phenobarbital and potassium bromide at doses sufficient to reach acceptable therapeutic serum levels without causing significant side effects. In each dog, the number of seizures per week, the average duration of the seizures and the number of days on which seizures occurred were compared for the three months before and after they were treated with gabapentin. A minimum 50 per cent reduction in the number of seizures per week was interpreted as a positive response to gabapentin, and six of the dogs showed a positive response. After the addition of gabapentin, both the number of seizures per week (P= 0·005) and the number of days with any seizures in a one-week period (P=0·03) were significantly reduced. Mild side effects of ataxia and sedation were observed in five of the dogs, but they were not severe enough to warrant the treatment being discontinued during the trial.






HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 2006 British Veterinary Association